Dr. Daniel Munguía, Pectus Up’s leading surgeon in Mexico, contributed to the launch of this innovative surgical technique at Hospital Ángeles Roma.
Last November, the Pectus Up, an extrathoracic implant to fix Pectus Excavatum, began its trajectory in Mexico City.
Two 12- and 15-year-old patients were operated on by Dr. Daniel Munguía, a thoracic surgeon, and Dr. Jorge Leyva, a cardiothoracic surgeon, with highly satisfactory results.
Dr. Daniel Munguía began his training in the Pectus Up technique in Monterrey in December 2018, and completed his training in Barcelona, in a surgery performed by Dr. Laureano Molins, a surgeon specialized in Pectus Excavatum.
Munguía is in charge of Thoracic Surgery-Pulmonary Transplantation at the Centro Médico Nacional Siglo XXI del IMSS and of chest surgery at the Hospital Regional de Alta Especialidad Bicentenario de Tultitlan. He is also a member of several scientific societies such as the EACTS.
The scenario of the Pectus Up opening in Mexico City was the Hospital Ángeles Roma, a leading center belonging to Grupo Empresarial Ángeles, a Mexican company that owns a large number of hospitals throughout the country.
Two surgeons from Costa Rica, Dr. Andrea Mata and Dr. William Guido, thoracic surgeons, and two from Mexico, Dr. Gerardo Lugo, a thoracic surgeon, and Dr. Izchel Valdez, a thoracic pediatrician surgeon, also participated in both surgeries.
Their attendance was part of a training for the surgeons to be able to offer the technique to their Pectus Excavatum patients.
This training was organized by Ventura Medical Technologies, the company that developed the Pectus Up, together with Nnova Mederi, distributor of the implant in Mexico, and Dr. Munguía himself.
The training programs are synonymous with the guarantee that patients affected by Pectus Excavatum benefit from this new method compared to other classic and more invasive systems.
The Pectus Up offers a minimally invasive solution for the treatment of Pectus Excavatum. It is an extrathoracic method that stands out for the low presence of pain and the rapid return of the patient into daily life.
It is currently available in Spain, France and Portugal in Europe, and in Colombia, Mexico, Chile and Costa Rica in Latin America.